维普中文期刊产品整合服务
107篇 您的检索式:作者名="Tins J"
    题名 作者 年代 出处 被引量
1Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience显示文摘AIM To evaluate the long-term treatment outcomes of tenofovir therapy in patients in a real world Australian tertiary care setting.METHODS We performed a retrospective analysis of treatment outcomes among treatment-na?ve and treatment-experienced patients receiving a minimum 3 mo tenofovir therapy through St Vincent's Hospital Melbourne, Australia. We included patients receiving tenofovir [tenofovir disoproxil fumarate(TDF)] monotherapy, as well as patients treated with TDF in combination with a second antiviral agent. Patients were excluded if they demonstrated human immune-deficiency virus/hepatitis C virus/hepatitis delta virus coinfection or were less than 18 years of age. We considered virological and biochemicalresponse, as well as safety outcomes. Virological response was determined by measurement of hepatitis B virus(HBV) DNA using sensitive assays; biochemical response was determined via serum liver function tests; histological response was determined from liver biopsy and fibroscan; safety analysis focused on glomerular renal function and bone mineral density. The primary efficacy endpoint was complete virological suppression over time, defined by HBV DNA < 20 IU/m L. Secondary efficacy endpoints included rates of biochemical response, and HB e antigen(HBe Ag)/HB surface antigen loss and seroconversion over time.RESULTS Ninety-two patients were identified who fulfilled the enrolment criteria. Median follow-up was 26 mo(range 3-114). Mean age was 46(24-78) years, 64(70%) were male and 77(84%) were of Asian origin. 55(60%) patients were treatment-na?ve and 62 patients(67%) were HBe Ag-negative. Complete virological suppression was achieved by 45/65(71%) patients at 12 mo, 37/46(80%) at 24 mo and 25/28(89%) at 36 mo. Partial virological response(HBV DNA 20-2000 IU/m L) was achieved by 89/92(96.7%) of patients. Multivariate analysis showed a significant relationship between virological suppression at end of follow-up and baseline HBV DNA level(OR = 0.897, 95%CI: 0.833-0.967, P = 0.0046) and HBe Ag positive status(OR = 0.373, 95%CI: 0.183-0.762, P = 0.0069). There was no difference in response comparing treatment-na?ve and treatment-experienced patients. Three episodes of virological breakthrough occurred in the setting of noncompliance. Tenofovir therapy was well tolerated.CONCLUSION Tenofovir is an efficacious, safe and well-tolerated treatment in an Australian real-world tertiary care setting. Our data are similar to the reported experience from registration trials.Grace C Lovett Tin Nguyen David M Iser Jacinta A Holmes Robert Chen Barbara Demediuk Gideon Shaw Sally J Bell Paul V Desmond Alexander J Thompson 2017World Journal of Hepatology2017,9,1:7
2IL 28 B genotype is not useful for predicting treatment outcome in A sian chronic hepatitis B patients treated with pegylated interferon‐α显示文摘Jacinta A Holmes Tin Nguyen Dilip Ratnam Neel M Heerasing Jane V Tehan Sara Bonanzinga Anouk Dev Sally Bell Stephen Pianko Robert Chen Kumar Visvanathan Rachel Hammond David Iser Ferry Rusli William Sievert Paul V Desmond D Scott Bowden Alexander J Thomps 2013J Gastroenterol Hepatol2013,,5:2
3Automatic test data generation for path testing using GAS显示文摘J C Tin P L Yeh 2001Information Science2001,131,1:1
4The shaft resistance of axially loaded Piles in clay 显示文摘Potts D M Mas'tins J P 1982Geotechnique1982,32,4:1
5Novel brain reactive autoantibodies: prevalence in systemic lupus erythematosus and association with psychoses and seizures显示文摘Tin SK Xu Q Thumboo J 2005Neuroimmunol2005,169,12:1
6Limita tion of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma 显示文摘WALDRON J TIN M M KELLER A 2003Radiother Oncol2003,68,:1
7Visual evoked potential as prognostic factor for vitrectomy in diabetic eyes显示文摘Scherfig E Tinning S Edmund J 1983Acta Ophthalmol1983,61,5:1
8Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma 显示文摘Waldron J Tin MM Keller A 2003Radiother Oncol2003,68,2:1
9Chance-type flexiondistraction injurirs in the thoracolumbar spine : MR imaging characteristies 显示文摘Groves C J Cassar-Pullicino VN Tins B J 2005Radiology2005,236,2:1
10Autologous chondrocyte implantation in knee joint: Mr imaging and histologic features at 1-year follow-up显示文摘Tins B J Mccall IW Takahashi T 2005Radiology2005,234,2:1
11A randomized controlled trial to compare steroid with cyclosporine for theopical treatment of oral lichen planus显示文摘Yoke PC Tin GB Kim M J 2006Oral Surg Oral Med Oral Pathol Oral Radiol Endod2006,102,1:1
12L imitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma 显示文摘Waldron J Tin MM Keller A 2003Radiother Oneo12003,68,2:1
13Improved inversion channel mobility for 4H-SiC MOSFETs following high temperature anneals in nitric oxide显示文摘CHUNG G Y TIN C C WILLIAMS J R 2001IEEE Electron Devives Letters2001,22,4:1
14Directional solidification of large superalloy castings with radiation and liquid-metal cooling:a comparative assessment显示文摘Elliott A J Tin S Pollock T M 2004Metallurgical and Materials Transactions A2004,35,:1
15Angle closure and angle‐closure glaucoma: what we are doing now and what we will be doing in the future显示文摘David S Friedman Paul J Foster Tin Aung Mingguang He 2012Clinical & Experimental Ophthalmology2012,,4:1
16Practice of sedation and ana- lgesia in German intensive care units:resuhs of a national sur- vey显示文摘Mar tin J Parsch A Martin F 2005Crit Care2005,9,2:1
17Gas exchange in litchi under controlled and field conditions显示文摘Chang J C tin T S 2007Scientia Horticulturae2007,114,4:1
18Silylation and surface properties of chemi- cally grafted hydrophobic silica显示文摘CAPEL-SANCHEZ M C BARRIO L CAMPOS-MAR- TIN J M 2004Journal of Colloid and Interface Science2004,277,1:1
19Analysis of throm- bopoietin receptor(c-mpl) mRNA expression in de novo acute myeloid leukemia显示文摘Schroder JK Kolkenbrock S Tins J 2000Leuk Res2000,24,5:1
20p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Star3 显示文摘Lin J Tang H Tin X 2002Oncogene2002,21,19:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费